Skip to main content
logo
  • Healthcare professional
  • LFB Group
Logo Equilibrium
X
  • Home
  • About EquilYbrium
    • Steering Committee members
  • Immunodeficiencies
    • Primary Immunodeficiencies
      • ADVANCED CARE IN PID: From birth to adulthood: LFB Symposium IPIC 2015
      • THE IMMUNOLOGIST CONSULTATION; Recognizing the signs of X-linked agammaglobulinemia
      • NEW INSIGHTS IN THE USE OF INTRAVENOUS IMMUNOGLOBULINS: How to enhance PID patients clinical outcomes ?
    • Secondary Immunodeficiencies
      • SID IN A HEART TRANSPLANT PATIENT
      • SID IN CLL PATIENT
  • Immunomodulation
    • Guillain-Barré Syndrome (GBS)
      • Guillain Barré Syndrome : From diagnosis to treatment
    • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
      • CIDP Educational Slides Deck
      • New insights in the use of intravenous
        immunoglobulins
      • Serious game: NeuroSims
      • CIDP response to Ig: What, When and How?
      • CIDP: Early treatment escalation in non-IVIg responders. A debate
    • Multifocal Motor neuropathy (MMN)
      • Evidence - based medicine and current advances in multifocal motor neuropathy
    • Congresses highlights
      • PNS 2020 Congress - Selected research presentation
      • PNS - ICNMD 2022 congresses - Selected research presentations
    • Guidelines
      • EAN/PNS CIDP Guidelines 2021 - Dr. Luis Querol Lecture
  • Research Grant

Sitemap

  • Home
  • About EquilYbrium
    • Steering Committee members
  • Immunodeficiencies
    • Primary Immunodeficiencies
    • Secondary Immunodeficiencies
  • Immunomodulation
    • Guillain-Barré Syndrome (GBS)
    • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
    • Multifocal Motor neuropathy (MMN)
    • Congresses highlights
    • Guidelines
  • Research Grant
  • Home
  • About EquilYbrium
    • Steering Committee members
  • Immunodeficiencies
    • Primary Immunodeficiencies
      • ADVANCED CARE IN PID: From birth to adulthood: LFB Symposium IPIC 2015
      • THE IMMUNOLOGIST CONSULTATION; Recognizing the signs of X-linked agammaglobulinemia
      • NEW INSIGHTS IN THE USE OF INTRAVENOUS IMMUNOGLOBULINS: How to enhance PID patients clinical outcomes ?
    • Secondary Immunodeficiencies
      • SID IN A HEART TRANSPLANT PATIENT
      • SID IN CLL PATIENT
  • Immunomodulation
    • Guillain-Barré Syndrome (GBS)
      • Guillain Barré Syndrome : From diagnosis to treatment
    • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
      • CIDP Educational Slides Deck
      • New insights in the use of intravenous
        immunoglobulins
      • Serious game: NeuroSims
      • CIDP response to Ig: What, When and How?
      • CIDP: Early treatment escalation in non-IVIg responders. A debate
    • Multifocal Motor neuropathy (MMN)
      • Evidence - based medicine and current advances in multifocal motor neuropathy
    • Congresses highlights
      • PNS 2020 Congress - Selected research presentation
      • PNS - ICNMD 2022 congresses - Selected research presentations
    • Guidelines
      • EAN/PNS CIDP Guidelines 2021 - Dr. Luis Querol Lecture
  • Research Grant
  • LFB Group

Public site

  • Home
  • About EquilYbrium
  • Immunodeficiencies
  • Immunomodulation
  • Other Therapeutic Uses
  • Contact
  • Sitemap
  • CGU
  • D-19-0180

This activity is funded by LFB.
D-19-0180

You will be redirected to the page : Presentation of the Grant

I accept ▸